Detalhe da pesquisa
1.
Treatment preferences as basis for decision making in patients using direct oral anticoagulants in Spain.
J Thromb Thrombolysis
; 51(2): 475-484, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-32594421
2.
Effect of concomitant antiplatelet therapy in patients with nonvalvular atrial fibrillation initiating non-vitamin K antagonists.
Eur J Clin Invest
; 49(10): e13161, 2019 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-31449685
3.
Kidney function monitoring and nonvitamin K oral anticoagulant dosage in atrial fibrillation.
Eur J Clin Invest
; 48(6): e12907, 2018 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-29423910
4.
Edoxaban Versus Low-Molecular-Weight Heparin in Hospitalized COVID-19 Patients With Atrial Fibrillation.
Clin Appl Thromb Hemost
; 29: 10760296231180865, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37282505
5.
Impact of atrial fibrillation and anticoagulation on the risk of death, thromboembolic disease and bleeding in patients with COVID-19: the ACO-VID Registry.
Curr Med Res Opin
; 39(6): 811-817, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37189306
6.
Impact of New Onset Atrial Fibrillation in Hospitalized Patients with COVID-19. Results of the "ACO-VID" Registry.
Clin Appl Thromb Hemost
; 29: 10760296231208440, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37899606
7.
Dabigatran in patients with atrial fibrillation after COVID-19 hospitalization: an update of the ANIBAL protocol.
Drugs Context
; 112022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35145555
8.
Real life behaviour of direct oral anticoagulants in patients with nonvalvular atrial fibrillation and morbid obesity.
Int J Cardiol Heart Vasc
; 37: 100913, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34825048
9.
Dabigatran, the oral anticoagulant of choice at discharge in patients with non-valvular atrial fibrillation and COVID-19 infection: the ANIBAL protocol.
Drugs Context
; 92020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33014097
10.
Aortic valve stenosis provides complementary information to bleeding risk scores in non-valvular atrial fibrillation patients initiating anticoagulation.
J Geriatr Cardiol
; 17(3): 141-148, 2020 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-32280330
11.
Use of edoxaban in clinical practice: Comparison of data from the Spanish population in the ETNA-AF-Europe registry.
Future Cardiol
; 16(5): 469-480, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32228182
12.
Real-life behaviour of direct oral anticoagulants in a Spanish cohort with non-valvular atrial fibrillation: Refase Registry.
Curr Med Res Opin
; 35(12): 2035-2041, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31335222
13.
Prevalence and Prognostic Implications of Valve Disease in Patients With Atrial Fibrillation Initiating Direct Oral Anticoagulants.
Rev Esp Cardiol (Engl Ed)
; 72(11): 935-943, 2019 Nov.
Artigo
em Inglês, Espanhol
| MEDLINE | ID: mdl-30497945
14.
Effectiveness and safety of rivaroxaban in nonvalvular atrial fibrillation: data from a contemporary Spanish registry.
Curr Med Res Opin
; 35(8): 1463-1471, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30912682
15.
Effectiveness and safety of rivaroxaban in a cohort of 142 patients with nonvalvular atrial fibrillation treated with rivaroxaban for the prevention of stroke.
Future Cardiol
; 14(3s): 31-37, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29848091
16.
Congenital factor XI deficiency and risk of heart failure in humans.
J Thromb Haemost
; 21(9): 2626-2629, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37336435
17.
Genotype-guided therapy improves initial acenocoumarol dosing. Results from a prospective randomised study.
Thromb Haemost
; 115(1): 117-25, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26538428
18.
Effect of VKORC1, CYP2C9 and CYP4F2 genetic variants in early outcomes during acenocoumarol treatment.
Pharmacogenomics
; 15(7): 987-96, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24956252